Comparison of PI-RADS and LIKERT scoring systems in the diagnosis of prostate cancer and the contribution of radiologist experience

被引:0
|
作者
Topaloglu, Ali Can [1 ]
Akkaya, Hueseyin [2 ]
Kaya, Oemer [3 ]
Ipek, Goekhan [4 ]
Dilek, Okan [4 ]
Oezdemir, Selim [5 ]
Gulek, Bozkurt [4 ]
Soeker, Goekhan [4 ]
机构
[1] Sanliurfa Training & Res Hosp, Sanliurfa, Turkiye
[2] Ondokuz Mayis Univ, Samsun, Turkiye
[3] Cukurova Univ, Adana, Turkiye
[4] Univ Hlth Sci, Adana, Turkiye
[5] Osmaniye State Hosp, Osmaniye, Turkiye
来源
CUKUROVA MEDICAL JOURNAL | 2025年 / 50卷 / 01期
关键词
Prostate cancer; PI-RADS v2.1; LIKERT; Multiparametric MRI; PSA; VALIDATION; V2;
D O I
10.17826/cumj.1608411
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: The aim of this study was to investigate the concordance of these two scoring systems with histopathological data and the relationship between this concordance and radiologist experience. Materials and Methods: A total of 347 patients who underwent multiparametric prostate MRI (mpMRI) with a preliminary diagnosis of prostate cancer were retrospectively reviewed. The assessors independently scored the images according to PI-RADS v2.1. Two weeks later, they independently scored the images using the LIKERT system while blinded to their previous PI-RADS v2.1 scores. The study investigated the correlation of these scores with the pathology results and the inter-reader agreement. Results: The mean age of the patients was 65.5 +/- 7.7 years. In the kappa analysis, which evaluated the concordance of both scoring systems with the reference standard pathology, it was observed that concordance increased with radiologist experience. For the entire gland, the kappa values for readers 1, 2, 3, and 4 with PI-RADS v2.1 were found to be 0.669, 0.669, 0.711, and 0.771, respectively, and with the LIKERT system, they were 0.589, 0.669, 0.701, and 0.771, respectively. The AUC values were 0.901 (0.893-0.921) for PI-RADS and 0.895 (0.871-0.922) for LIKERT. Conclusion: The PI-RADS v2.1 and LIKERT scoring systems provided similar inter-reader agreement in evaluating mpMRI. Among less experienced radiologists, PI-RADS v2.1 demonstrated higher concordance with pathology, whereas no difference was observed between more experienced radiologists.
引用
收藏
页码:106 / 114
页数:9
相关论文
共 50 条
  • [41] MRI in early prostate cancer detection: how to manage indeterminate or equivocal PI-RADS 3 lesions?
    Schoots, Ivo G.
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2018, 7 (01) : 70 - +
  • [42] Comparison in prostate cancer diagnosis with PSA 4-10 ng/mL: radiomics-based model VS. PI-RADS v2.1
    Li, Chunxing
    Jin, Zhicheng
    Wei, Chaogang
    Dai, Guangcheng
    Tu, Jian
    Shen, Junkang
    BMC UROLOGY, 2024, 24 (01):
  • [43] Optimizing Multiparametric MRI Protocols for Prostate Cancer Detection: A Comprehensive Assessment Aligned with PI-RADS Guidelines
    Jamshidi, Mohammad Hossein
    Fatemi, Ali
    Karami, Aida
    Ghanavati, Sepehr
    Dhruba, Durjoy D.
    Negarestanian, Mohammad H.
    HEALTH SCIENCE REPORTS, 2024, 7 (11)
  • [44] Prognostic significance of the PI-RADS score in men with prostate cancer undergoing radical prostatectomy
    Nwanze, Julum
    Teramoto, Yuki
    Wang, Ying
    Miyamoto, Hiroshi
    AMERICAN JOURNAL OF CLINICAL AND EXPERIMENTAL UROLOGY, 2024, 12 (04): : 162 - 172
  • [45] Standardized Reporting of Prostate MRI: Comparison of the Prostate Imaging Reporting and Data System (PI-RADS) Version 1 and Version 2
    Tewes, Susanne
    Mokov, Nikolaj
    Hartung, Dagmar
    Schick, Volker
    Peters, Inga
    Schedl, Peter
    Pertschy, Stefanie
    Wacker, Frank
    Voshage, Goetz
    Hueper, Katja
    PLOS ONE, 2016, 11 (09):
  • [46] Preoperative MRI PI-RADS scores are associated with prostate cancer upstaging on surgical pathology
    Pockros, Benjamin
    Stensland, Kristian D.
    Parries, Molly
    Frankenberger, Edward
    Canes, David
    Moinzadeh, Alireza
    PROSTATE, 2022, 82 (03) : 352 - 358
  • [47] Differentiation of prostatitis and prostate cancer using the Prostate Imaging-Reporting and Data System (PI-RADS)
    Meier-Schroers, Michael
    Kukuk, Guido
    Wolter, Karsten
    Decker, Georges
    Fischer, Stefan
    Marx, Christian
    Traeber, Frank
    Sprinkart, Alois Martin
    Block, Wolfgang
    Schild, Hans Heinz
    Willinek, Winfried
    EUROPEAN JOURNAL OF RADIOLOGY, 2016, 85 (07) : 1304 - 1311
  • [48] Evaluation of the PI-RADS scoring system for mpMRI of the prostate: a whole-mount step-section analysis
    Junker, Daniel
    Quentin, Michael
    Nagele, Udo
    Edlinger, Michael
    Richenberg, Jonathan
    Schaefer, Georg
    Ladurner, Michael
    Jaschke, Werner
    Horninger, Wolfgang
    Aigner, Friedrich
    WORLD JOURNAL OF UROLOGY, 2015, 33 (07) : 1023 - 1030
  • [49] The function of Prostate Health Index in detecting clinically significant prostate cancer in the PI-RADS 3 population: a multicenter prospective study
    Zhou, Yongheng
    Fu, Qiang
    Shao, Zhiqiang
    Qi, Wenqiang
    Zhong, Minglei
    Lv, Guangda
    Jiang, Zhiwen
    Zhu, Meikai
    Wang, Wenfu
    Shi, Benkang
    Chen, Shouzhen
    Zhu, Yaofeng
    WORLD JOURNAL OF UROLOGY, 2023, 41 (2) : 455 - 461
  • [50] PI-RADS upgrading as the strongest predictor for the presence of clinically significant prostate cancer in patients with initial PI-RADS-3 lesions
    Kwe, Jeremy
    Baunacke, Martin
    Boehm, Katharina
    Platzek, Ivan
    Thomas, Christian
    Borkowetz, Angelika
    WORLD JOURNAL OF UROLOGY, 2024, 42 (01)